199 related articles for article (PubMed ID: 28458041)
1. The neuroprotective effect of focused ultrasound: New perspectives on an old tool.
Yulug B; Hanoglu L; Kilic E
Brain Res Bull; 2017 May; 131():199-206. PubMed ID: 28458041
[TBL] [Abstract][Full Text] [Related]
2. Transcranial focused ultrasound as a possible treatment for major depression.
Tsai SJ
Med Hypotheses; 2015 Apr; 84(4):381-3. PubMed ID: 25665863
[TBL] [Abstract][Full Text] [Related]
3. New horizons for focused ultrasound (FUS) - therapeutic applications in neurodegenerative diseases.
Miller DB; O'Callaghan JP
Metabolism; 2017 Apr; 69S():S3-S7. PubMed ID: 28159329
[TBL] [Abstract][Full Text] [Related]
4. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic factors and neurodegenerative diseases: a delivery issue.
Ruozi B; Belletti D; Bondioli L; De Vita A; Forni F; Vandelli MA; Tosi G
Int Rev Neurobiol; 2012; 102():207-47. PubMed ID: 22748832
[TBL] [Abstract][Full Text] [Related]
6. Safety of transcranial focused ultrasound stimulation: A systematic review of the state of knowledge from both human and animal studies.
Pasquinelli C; Hanson LG; Siebner HR; Lee HJ; Thielscher A
Brain Stimul; 2019; 12(6):1367-1380. PubMed ID: 31401074
[TBL] [Abstract][Full Text] [Related]
7. The use of transcranial focused ultrasound in CNS diseases.
Galkin MV
Zh Vopr Neirokhir Im N N Burdenko; 2016; 80(2):108-118. PubMed ID: 27331236
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery.
Nainwal N
Curr Drug Targets; 2017; 18(11):1225-1232. PubMed ID: 28017126
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.
Fan CH; Ting CY; Lin CY; Chan HL; Chang YC; Chen YY; Liu HL; Yeh CK
Sci Rep; 2016 Jan; 6():19579. PubMed ID: 26786201
[TBL] [Abstract][Full Text] [Related]
10. Enhanced delivery and bioactivity of the neurturin neurotrophic factor through focused ultrasound-mediated blood--brain barrier opening in vivo.
Samiotaki G; Acosta C; Wang S; Konofagou EE
J Cereb Blood Flow Metab; 2015 Mar; 35(4):611-22. PubMed ID: 25586140
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive, neuron-specific gene therapy by focused ultrasound-induced blood-brain barrier opening in Parkinson's disease mouse model.
Lin CY; Hsieh HY; Chen CM; Wu SR; Tsai CH; Huang CY; Hua MY; Wei KC; Yeh CK; Liu HL
J Control Release; 2016 Aug; 235():72-81. PubMed ID: 27235980
[TBL] [Abstract][Full Text] [Related]
12. Focused ultrasound-mediated drug delivery through the blood-brain barrier.
Burgess A; Shah K; Hough O; Hynynen K
Expert Rev Neurother; 2015 May; 15(5):477-91. PubMed ID: 25936845
[TBL] [Abstract][Full Text] [Related]
13. A review of functional neuromodulation in humans using low-intensity transcranial focused ultrasound.
Lee K; Park TY; Lee W; Kim H
Biomed Eng Lett; 2024 May; 14(3):407-438. PubMed ID: 38645585
[TBL] [Abstract][Full Text] [Related]
14. Drug development in Parkinson's disease: from emerging molecules to innovative drug delivery systems.
Garbayo E; Ansorena E; Blanco-Prieto MJ
Maturitas; 2013 Nov; 76(3):272-8. PubMed ID: 23827471
[TBL] [Abstract][Full Text] [Related]
15. A pilot clinical study of low-intensity transcranial focused ultrasound in Alzheimer's disease.
Jeong H; Im JJ; Park JS; Na SH; Lee W; Yoo SS; Song IU; Chung YA
Ultrasonography; 2021 Oct; 40(4):512-519. PubMed ID: 33730775
[TBL] [Abstract][Full Text] [Related]
16. Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Burgess A; Nhan T; Moffatt C; Klibanov AL; Hynynen K
J Control Release; 2014 Oct; 192():243-8. PubMed ID: 25107692
[TBL] [Abstract][Full Text] [Related]
17. Impacts of methylxanthines and adenosine receptors on neurodegeneration: human and experimental studies.
Chen JF; Chern Y
Handb Exp Pharmacol; 2011; (200):267-310. PubMed ID: 20859800
[TBL] [Abstract][Full Text] [Related]
18. Focused ultrasound as a non-invasive intervention for neurological disease: a review.
Piper RJ; Hughes MA; Moran CM; Kandasamy J
Br J Neurosurg; 2016 Jun; 30(3):286-93. PubMed ID: 27101792
[TBL] [Abstract][Full Text] [Related]
19. In Vivo application and localization of transcranial focused ultrasound using dual-mode ultrasound arrays.
Haritonova A; Liu D; Ebbini ES
IEEE Trans Ultrason Ferroelectr Freq Control; 2015 Dec; 62(12):2031-42. PubMed ID: 26670845
[TBL] [Abstract][Full Text] [Related]
20. The Neuroprotective Role of Repetitive Transcranial Magnetic Stimulation (rTMS) for Neurodegenerative Diseases: A Short Review on Experimental Studies.
Yulug B; Hanoglu L; Kilic E; Polat B; Schabitz WR
Mini Rev Med Chem; 2016; 16(16):1269-1273. PubMed ID: 27211308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
